BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26662806)

  • 1. Assessment of changes in expression and presentation of NKG2D under influence of MICA serum factor in different stages of breast cancer.
    Roshani R; Boroujerdnia MG; Talaiezadeh AH; Khodadadi A
    Tumour Biol; 2016 May; 37(5):6953-62. PubMed ID: 26662806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.
    Arreygue-Garcia NA; Daneri-Navarro A; del Toro-Arreola A; Cid-Arregui A; Gonzalez-Ramella O; Jave-Suarez LF; Aguilar-Lemarroy A; Troyo-Sanroman R; Bravo-Cuellar A; Delgado-Rizo V; Garcia-Iglesias T; Hernandez-Flores G; Del Toro-Arreola S
    BMC Cancer; 2008 Jan; 8():16. PubMed ID: 18208618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The roles of soluble MICA in immune escape of breast tumor].
    Ye YB; Zhou ZF; Chen Q; Li JY; Chen X; Huang WW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):904-7. PubMed ID: 18782524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer.
    Duan X; Deng L; Chen X; Lu Y; Zhang Q; Zhang K; Hu Y; Zeng J; Sun W
    Med Oncol; 2011 Jun; 28(2):466-74. PubMed ID: 20354827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma.
    Li JJ; Pan K; Gu MF; Chen MS; Zhao JJ; Wang H; Liang XT; Sun JC; Xia JC
    Chin J Cancer; 2013 Mar; 32(3):141-8. PubMed ID: 22704489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The soluble major histocompatibility complex class I-related chain A protein reduced NKG2D expression on natural killer and T cells from patients with prolactinoma and non-secreting pituitary adenoma.
    Ma L; Li G; Su Y; He Q; Zhang C; Zhang J
    J Clin Neurosci; 2010 Feb; 17(2):241-7. PubMed ID: 20045334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered NK-cell compartment and dysfunctional NKG2D/NKG2D-ligand axis in patients with ataxia-telangiectasia.
    Desimio MG; Finocchi A; Di Matteo G; Di Cesare S; Giancotta C; Conti F; Chessa L; Piane M; Montin D; Dellepiane M; Rossi P; Cancrini C; Doria M
    Clin Immunol; 2021 Sep; 230():108802. PubMed ID: 34298181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of membrane/soluble MHC class I chain-related molecule A and NKG2D receptor in osteosarcoma and its clinical significance].
    Xiao P; Xue L; Che LH; Wu HX; Qiao H
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):596-9. PubMed ID: 18070447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.
    Jinushi M; Takehara T; Tatsumi T; Hiramatsu N; Sakamori R; Yamaguchi S; Hayashi N
    J Hepatol; 2005 Dec; 43(6):1013-20. PubMed ID: 16168521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble MICA in malignant diseases.
    Holdenrieder S; Stieber P; Peterfi A; Nagel D; Steinle A; Salih HR
    Int J Cancer; 2006 Feb; 118(3):684-7. PubMed ID: 16094621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.
    Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P
    Front Immunol; 2021; 12():633658. PubMed ID: 34012432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
    Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U
    Eur J Immunol; 2010 Nov; 40(11):3255-67. PubMed ID: 21061445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection.
    Suárez-Alvarez B; López-Vázquez A; Díaz-Molina B; Bernardo-Rodríguez MJ; Alvarez-López R; Pascual D; Astudillo A; Martínez-Borra J; Lambert JL; González S; López-Larrea C
    Transplantation; 2006 Aug; 82(3):354-61. PubMed ID: 16906033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
    Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
    Front Immunol; 2018; 9():926. PubMed ID: 29765374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and clinical significance of CD8+natural killer T cell stimulatory receptor NKG2D in peripheral blood of lung cancer patients].
    Cheng N; Han F; Wang Y; Mai X; Su W
    Zhongguo Fei Ai Za Zhi; 2010 Oct; 13(10):962-7. PubMed ID: 20959069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The decrease in NKG2D+ Natural Killer cells in peripheral blood of patients with metastatic colorectal cancer.
    Gharagozloo M; Kalantari H; Rezaei A; Maracy MR; Salehi M; Bahador A; Hassannejad N; Narimani M; Sanei MH; Bayat B; Ghazanfari H
    Bratisl Lek Listy; 2015; 116(5):296-301. PubMed ID: 25924638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation Roles of MICA and NKG2D in Human Renal Cancer Cells.
    Jia HY; Liu JL; Yuan MZ; Zhou CJ; Sun WD; Zhao JJ; Wang J; Liu L; Luan Y
    Asian Pac J Cancer Prev; 2015; 16(9):3901-5. PubMed ID: 25987057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of peripheral blood natural killer cell surface CD
    Liu JX; Wang JW; Cui XY
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):872-874. PubMed ID: 27801344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
    Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
    Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.
    Verma C; Kaewkangsadan V; Eremin JM; Cowley GP; Ilyas M; El-Sheemy MA; Eremin O
    J Transl Med; 2015 Jun; 13():180. PubMed ID: 26040463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.